nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension
|
Lee, Jang Hoon |
|
2016 |
38 |
6 |
p. 1485-1497 13 p. |
artikel |
2 |
A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
|
Collatz, Ansel |
|
2016 |
38 |
6 |
p. 1263-1271.e9 1.270999998738E12 p. |
artikel |
3 |
Bioavailability of Methadone After Sleeve Gastrectomy: A Planned Case Observation
|
Strømmen, Magnus |
|
2016 |
38 |
6 |
p. 1532-1536 5 p. |
artikel |
4 |
Clinical Implications of Cardiovascular Outcome Trials in Type 2 Diabetes: From DCCT to EMPA-REG
|
Rydén, Lars |
|
2016 |
38 |
6 |
p. 1279-1287 9 p. |
artikel |
5 |
Clinical Utility of Basophil CD203c as a Biomarker for Predicting the Timing of Hypersensitivity Reaction in Carboplatin Rechallenge: Three Case Reports
|
Iwamoto, Takuya |
|
2016 |
38 |
6 |
p. 1537-1541 5 p. |
artikel |
6 |
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial
|
Pinckney, Ashley |
|
2016 |
38 |
6 |
p. 1327-1339 13 p. |
artikel |
7 |
Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-level Data
|
Trautmann, Michael E. |
|
2016 |
38 |
6 |
p. 1464-1473 10 p. |
artikel |
8 |
Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy
|
Graham, Christopher N. |
|
2016 |
38 |
6 |
p. 1376-1391 16 p. |
artikel |
9 |
Editorial Board
|
|
|
2016 |
38 |
6 |
p. A2- 1 p. |
artikel |
10 |
Efficacy and Safety Profile of Anti–tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn’s Disease: A Network Meta-analysis of Indirect Comparisons
|
Miligkos, Michael |
|
2016 |
38 |
6 |
p. 1342-1358.e6 1.357998659E9 p. |
artikel |
11 |
Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study
|
Sanga, Panna |
|
2016 |
38 |
6 |
p. 1435-1450 16 p. |
artikel |
12 |
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus
|
Schernthaner, Guntram |
|
2016 |
38 |
6 |
p. 1288-1298 11 p. |
artikel |
13 |
Engaging Participants in Rare Disease Research: A Qualitative Study of Duchenne Muscular Dystrophy
|
Bendixen, Roxanna M. |
|
2016 |
38 |
6 |
p. 1474-1484.e2 146927 p. |
artikel |
14 |
Evidence for Good Cardiovascular Outcomes among Patients with Type 2 Diabetes, and Promising Treatment for Patients with Type 1 Diabetes
|
Ryan, John G. |
|
2016 |
38 |
6 |
p. 1274-1278 5 p. |
artikel |
15 |
Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases
|
Harnett, James |
|
2016 |
38 |
6 |
p. 1451-1463 13 p. |
artikel |
16 |
Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012
|
Weng, Wayne |
|
2016 |
38 |
6 |
p. 1314-1326 13 p. |
artikel |
17 |
Lorcaserin in Obese and Overweight Patients Taking Prohibited Serotonergic Agents: A Retrospective Analysis
|
Nguyen, Charles T. |
|
2016 |
38 |
6 |
p. 1498-1509 12 p. |
artikel |
18 |
Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012–2013)
|
Zalacain, Magdalena |
|
2016 |
38 |
6 |
p. 1510-1521 12 p. |
artikel |
19 |
Rescue Sedation With Intranasal Dexmedetomidine for Pediatric Ophthalmic Examination After Chloral Hydrate Failure: A Randomized, Controlled Trial
|
Gan, Xiaoliang |
|
2016 |
38 |
6 |
p. 1522-1529 8 p. |
artikel |
20 |
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes
|
Kohler, Sven |
|
2016 |
38 |
6 |
p. 1299-1313 15 p. |
artikel |
21 |
Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study
|
Chen, Christopher B. |
|
2016 |
38 |
6 |
p. 1392-1400 9 p. |
artikel |
22 |
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects
|
Bhattacharya, Indranil |
|
2016 |
38 |
6 |
p. 1401-1416 16 p. |
artikel |
23 |
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus
|
Cohen, Stanley |
|
2016 |
38 |
6 |
p. 1417-1434.e2 141984 p. |
artikel |
24 |
Some Reflections on Diabetes Mellitus
|
Shader, Richard I. |
|
2016 |
38 |
6 |
p. 1259-1261 3 p. |
artikel |
25 |
Table of Contents
|
|
|
2016 |
38 |
6 |
p. A4-A6 nvt p. |
artikel |
26 |
Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data
|
Sugiyama, Naonobu |
|
2016 |
38 |
6 |
p. 1359-1375.e1 12392 p. |
artikel |